Clinical Trial Update: A Trial to Investigate the Effects of Cannabidiol Plus Naltrexone on Alcohol Craving in Patients With Alcohol Dependence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cannabidiol plus naltrexone for reducing alcohol craving in adults with alcohol use disorder; recruitment is ongoing in Mannhe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Cannabidiol (cannabidiol)
• Naltrexone (Naltrexone)

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Alcohol Addiction, Alcoholism | Phase 2 | Status: RECRUITING